Humoral immune response to COVID-19 vaccine in patients with myasthenia gravis

被引：2

作者：

Holm-Yildiz, Sonja ^{[1
,10
]}

Dysgaard, Tina ^{[1
]}

Krag, Thomas ^{[1
]}

Pedersen, Britt Staevnsbo ^{[1
]}

Hamm, Sebastian Rask ^{[2
]}

Perez-Alos, Laura ^{[3
]}

Hansen, Cecilie Bo ^{[3
]}

Pries-Heje, Mia Marie ^{[4
]}

Heftdal, Line Dam ^{[2
]}

Hasselbalch, Rasmus Bo ^{[5
]}

Fogh, Kamille ^{[5
]}

Madsen, Johannes Roth ^{[3
]}

Frikke-Schmidt, Ruth ^{[6
,7
]}

Hilsted, Linda Maria ^{[6
]}

Sorensen, Erik ^{[8
]}

Ostrowski, Sisse Rye ^{[7
,8
]}

Bundgaard, Henning ^{[4
,7
]}

Garred, Peter ^{[3
,7
]}

Iversen, Kasper ^{[5
,7
,9
]}

Nielsen, Susanne Dam ^{[2
]}

Vissing, John ^{[1
]}

机构：

[1] Univ Copenhagen, Copenhagen Neuromuscular Ctr, Righosp, Dept Neurol, Copenhagen, Denmark

[2] Copenhagen Univ Hosp, Dept Infect Dis, Rigshosp, Viro Immunol Res Unit, Copenhagen, Denmark

[3] Copenhagen Univ Hosp, Dept Clin Immunol, Righosp, Lab Mol Med, Sect 7631, Copenhagen, Denmark

[4] Copenhagen Univ Hosp, Dept Cardiol, Rigshosp, Copenhagen, Denmark

[5] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Cardiol, Copenhagen, Denmark

[6] Copenhagen Univ Hosp, Dept Clin Biochem, Rigshosp, Copenhagen, Denmark

[7] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark

[8] Copenhagen Univ Hosp, Dept Clin Immunol, Rigshosp, Copenhagen, Denmark

[9] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Emergency Med, Copenhagen, Denmark

[10] Rigshosp, Dept Neurol 8077, Inge Lehmanns Vej 8, DK-2100 Copenhagen, Denmark

来源：

JOURNAL OF NEUROIMMUNOLOGY | 2023年 / 384卷

关键词：

Myasthenia gravis; COVID-19; vaccine; BNT162b2; Humoral response; TETANUS;

D O I：

10.1016/j.jneuroim.2023.578215

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We investigated the humoral response to the Pfizer-BioNTech COVID-19 (BNT162b2) vaccine in patients with myasthenia gravis on or off immunosuppressants and compared this to the response in healthy individuals. The SARS-CoV-2 IgG response and neutralizing capacity were measured in 83 patients (57 on immunosuppressants) and 332 healthy controls at baseline, three weeks, and two and six months after the vaccine. We found that the proportion of positive humoral response was lower in patients on immunosuppressants vs. controls at three weeks and two months (p <= 0.001), but not at six months post-vaccination (p = 0.379).

引用

页数：5

共 50 条

[21] Post COVID-19 Myasthenia Gravis
Rogers, Nathaniel
Crabtree, Elizabeth
NEUROLOGY, 2023, 100 (17)
[22] EFFECT OF COVID-19 ON MYASTHENIA GRAVIS
Quezada, Timothy
Small, George
MUSCLE & NERVE, 2021, 64 : S79 - S79
[23] Humoral Response to COVID-19 Vaccine: A Challenge in CLL
Capasso, Antonella
Albi, Elisa
Schiattone, Luana
Martini, Francesca
Sant'Antonio, Emanuela
Scarfo, Lydia
Ranghetti, Pamela
Frenquelli, Michela
Campanella, Alessandro
Perotta, Eleonora
Heltai, Silvia
Colia, Maria
Ghia, Paolo
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S279 - S280
[24] Evaluation of the humoral and mucosal immune response of a multiepitope vaccine against COVID-19 in pigs
Mosqueda, Juan
Hernandez-Silva, Diego Josimar
Vega-Lopez, Marco Antonio
Vega-Rojas, Lineth J.
Beltran, Rolando
Velasco-Elizondo, Andres
Ramirez-Estudillo, Maria del Carmen
Fragoso-Saavedra, Mario
Perez-Almeida, Chyntia
Hernandez, Jesus
Melgoza-Gonzalez, Edgar A.
Hinojosa-Trujillo, Diana
Mercado-Uriostegui, Miguel angel
Mejia-Lopez, Alma Susana
Rivera-Ballesteros, Carlos
Garcia-Gasca, Teresa
FRONTIERS IN IMMUNOLOGY, 2023, 14
[25] COVID-19 in Patients with Myasthenia Gravis: Mechanisms of Respiratory Failure
Murthy, Jagarlapudi M. K.
Gutta, Abhinay K.
Yerasu, Muralidhar Reddy
Boorgu, Santhosh Kumar
Osman, Syed
Jaiswal, Shyam K.
Pidaparthi, Lalitha
Gudavalli, Bhavani P.
NEUROLOGY INDIA, 2021, 69 (06) : 1772 - 1776
[26] Favipiravir Experience in Covid-19 Positive Myasthenia Gravis Patients
Yevgi, Recep
Bilge, Nuray
Simsek, Fatma
EURASIAN JOURNAL OF MEDICINE, 2021, 53 (02): : 164 - 165
[27] Case Series of Myasthenia Gravis patients with COVID-19 infection
Suri, Ritika
Chandok, Arun
Sripathi, Naganand
Grover, Kavita
NEUROLOGY, 2021, 96 (15)
[28] Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis
Frauke Stascheit
Ulrike Grittner
Sarah Hoffmann
Philipp Mergenthaler
Michael Schroeter
Tobias Ruck
Mark Pawlitzki
Franz Blaes
Julia Kaiser
Ulrike Schara
Adela Della-Marina
Andrea Thieme
Tim Hagenacker
Christian Jacobi
Benjamin Berger
Peter P. Urban
Karl Christian Knop
Berthold Schalke
De-Hyung Lee
Petra Kalischewski
Heinz Wiendl
Andreas Meisel
Journal of Neurology, 2023, 270 : 1 - 12
[29] ASSOCIATION BETWEEN MYASTHENIA GRAVIS AND OUTCOMES IN COVID-19 PATIENTS
Thepmankorn, Parisorn
Patlolla, Rishita
Heshmati, Keyvan
Malerba, Stefano
Arismendi, Gabriel
Souayah, Sami
Adam, Nabil
Souayah, Nizar
MUSCLE & NERVE, 2021, 64 : S12 - S12
[30] Clinical course and outcome of Covid-19 in patients with myasthenia gravis
Aktoz, Gonulden
Boz, Cavit
Zengin, Serap
Okumus, Aleyna Caglar
Horozoglu, Hilal
Kara, Fatma
Oral, Ebru
Ozmenoglu, Mehmet
NEUROLOGICAL RESEARCH, 2023, 45 (06) : 583 - 589

← 1 2 3 4 5 →